PeterLabs Holdings Bhd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.107x

PeterLabs Holdings Bhd cash flow conversion efficiency. Based on the latest financial reports, PeterLabs Holdings Bhd (0171) has a cash flow conversion efficiency ratio of 0.107x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (RM8.43 Million ≈ $2.12 Million USD) by net assets (RM78.60 Million ≈ $19.73 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see PeterLabs Holdings Bhd stock valuation for the company's overall valuation and market capitalisation.

Cash Flow Conversion Efficiency of PeterLabs Holdings Bhd (2015–2024)

Cash flow conversion efficiency of PeterLabs Holdings Bhd from 2015 to 2024. This chart illustrates how PeterLabs Holdings Bhd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 0171 stock price for real-time trading data and today's change.

PeterLabs Holdings Bhd Cash Flow Conversion Ratio Explained

PeterLabs Holdings Bhd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

PeterLabs Holdings Bhd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of PeterLabs Holdings Bhd ranked by their cash flow conversion efficiency. Review 0171 free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Company Cash Flow Conversion Efficiency
Inno Holdings Inc. Common Stock
NASDAQ:INHD
-0.063x
Is Girisim Sermayesi Yatirim Ortakligi AS
IS:ISGSY
-0.007x
CT AUTOMOTIVE GROUP -005
F:X7X
N/A
Watos Corea Co. Ltd
KQ:079000
-0.031x
Alpha Microelectronics
TWO:8024
-0.018x
Esotiq & Henderson S.A.
WAR:EAH
-0.138x
Alumindo Light Metal Industry
JK:ALMI
-0.016x
Flow Capital Corp
V:FW
-0.112x

Annual Cash Flow Conversion Efficiency for PeterLabs Holdings Bhd (2015–2024)

The table below shows the annual cash flow conversion efficiency of PeterLabs Holdings Bhd from 2015 to 2024. Also see total assets of PeterLabs Holdings Bhd for a full breakdown of the balance sheet.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 RM76.94 Million
≈ $19.32 Million
RM12.39 Million
≈ $3.11 Million
0.161x +125.23%
2023-12-31 RM75.76 Million
≈ $19.02 Million
RM5.42 Million
≈ $1.36 Million
0.071x +4690.19%
2022-12-31 RM74.37 Million
≈ $18.67 Million
RM111.00K
≈ $27.87K
0.001x +102.28%
2021-12-31 RM72.42 Million
≈ $18.18 Million
RM-4.74 Million
≈ $-1.19 Million
-0.065x -139.00%
2020-12-31 RM58.36 Million
≈ $14.65 Million
RM9.78 Million
≈ $2.46 Million
0.168x -16.76%
2019-12-31 RM52.47 Million
≈ $13.17 Million
RM10.57 Million
≈ $2.65 Million
0.201x +519.97%
2018-12-31 RM48.26 Million
≈ $12.12 Million
RM1.57 Million
≈ $393.66K
0.032x -18.48%
2017-12-31 RM45.74 Million
≈ $11.48 Million
RM1.82 Million
≈ $457.68K
0.040x -81.09%
2016-12-31 RM39.43 Million
≈ $9.90 Million
RM8.31 Million
≈ $2.09 Million
0.211x +876.31%
2015-12-31 RM38.99 Million
≈ $9.79 Million
RM-1.06 Million
≈ $-265.73K
-0.027x --

About PeterLabs Holdings Bhd

KLSE:0171 Malaysia Drug Manufacturers - Specialty & Generic
Market Cap
$16.58 Million
RM66.05 Million MYR
Market Cap Rank
#25557 Global
#725 in Malaysia
Share Price
RM0.24
Change (1 day)
-7.69%
52-Week Range
RM0.20 - RM0.28
All Time High
RM0.45
About

PeterLabs Holdings Berhad, an investment holding company, engages in manufacturing, distribution, trading, and export of animal health and nutrition products in Malaysia and internationally. The company operates through three segments: Manufacturing, Trading, and Others. It offers biosecurity products and disinfectants, compound feed supplements, feed additives, nutritional premixes, pharmaceutic… Read more